Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with insulin resistance. Further study is underway to fully explore the long-term ef